ArticleFrontiers in public health2024

The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain): a prospective population-based cohort study.

José Francisco Barbas Del Buey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.